Ethiopia-National-Expanded-Program-on-Immunization 2021
Ethiopia-National-Expanded-Program-on-Immunization 2021
Program on Immunization
COMPREHENSIVE MULTI-YEAR PLAN (2021-2025)
List of Figures i
List of Tables ii
List of Abbreviation iii
Acknowledgment iv
Preface v
Executive Summary 1
Chapter One - Country Information 2
1.1 Governance and demography 2
1.2 Socio-economic Situation 3
1.3 Health Problems of Mothers and Children in Ethiopia 3
1.4 Health System Organization 3
1.5 EPI Service Delivery 5
1.6 Rationale for the development of new cMYP (2021-2025) 5
Chapter Two - Situational Analysis 6
2.1 Expanded Programme on Immunization in Ethiopia 6
2.2. National Immunization Implementation Guideline 6
2.3 Immunization Service Delivery 7
2.3.1 Implementation of cMYP 2016 -2020 7
2.3.2 Achievements of Child, Infant and Neonatal Mortality Reduction 7
2.3.3 Performance of Routine Immunization during EFY 2008-2012 (2016-2020) 8
2.3.4 Immunization data quality 9
2.3.5 Routine Immunization Service Provision Platforms and Strategies 12
2.3.6 Reaching Every District/Child/ (RED/REC) Approach 13
2.3.7 Periodic Intensification of Routine Immunization (PIRI) 13
2.3.8 Urban Immunization 13
2.3.9 Catch- up vaccination 14
2.3.10 Impact of COVID-19 on Immunization Programme 14
2.3.11 New Vaccines Introduction 14
2.3.12 Polio SIAs and Progress in Polio Eradication Initiative 15
2.3.13 Measles SIAsW 17
2.3.14 Maternal and Neonatal Tetanus SIAs 19
2.3.15 Meningitis A vaccination campaign 20
2.4 Disease Surveillance 20
2.4.1 Vaccine-Preventable Diseases Surveillance 20
2.4.1.1 AFP Surveillance 21
2.4.1.2 Measles surveillance 22
2.4.1.3 Rubella Surveillance 25
2.4.1.4 Neonatal tetanus surveillance 26
2.4.1.5 Paediatric Bacterial Meningitis/Hib Surveillance 26
2.4.1.6 Rotavirus Surveillance 28
2.4.2 Laboratory 28
2.4.2.1 Polio Laboratory 28
2.4.2.3 Rota Laboratory 28
2.4.2.4 Bacteriology Laboratory 29
2.5 Immunization Supply Chain Management 29
2.5.1 Effective Vaccine Management 29
2.5.2 Cold Chain Equipment Management 33
2.5.3. Vaccine Direct Delivery 36
2.5.4 Injection safety and waste disposal 37
2.5.5 Vaccine, Supply and Quality 38
2.5.6 Adverse Event following immunization (AEFI) 38
2.6. EPI Advocacy, social mobilization and program communication 39
2.6.1 Advocacy 39
2.6.2 Community Engagement and Social Mobilization 39
2.6.3. Program Communication 40
2.6.3.1. Evidence Generation 40
2.6.3.2 Risk Communication 40
2.6.4. Challenges and gaps 40
2.7 Program Management 41
2.7.1 Planning 41
2.7.2 Administration and Coordination 41
2.7.3 Health Information system /Immunization data Management 42
2.7.4 Monitoring, Supervision and Evaluation 42
2.8 Strengthening human and institutional resources 44
2.8.1 Staffing 44
2.8.2 Capacity Building for EPI 44
2.8.2.1 Pre-service Training 44
2.8.2.2 In-service Training 44
2.8.3 Research and development 44
2.9 Partnership and financial sustainability 45
2.9.1 National EPI Stakeholder Analysis 45
2.9.2 GAVI support 47
2.9.3 Government Contribution 49
2.9.4 Other Donors: 49
2.9.5 Community participation 49
Chapter Three - Vision, Mission, Goals, Programme Objectives, Strategic Approaches, 57
Key Activities, Indicators and Milestones
3.1. Introduction 57
3.2. Vision 57
3.3. Mission 57
3.4. Goals of the cMYP (2021- 2025) 57
3.5 Program Objectives 57
3.6 Strategic Approaches 61
3.7 Anticipated Coverage Targets 64
3.8 Planning by immunization system component 80
Chapter Four - Costing, Financing and Financing Gaps 100
4.1 Macroeconomic Information 100
4.2 Methodology for costing the cMYP 100
4.2.1 Costing Assumptions 100
4.3 Costing of cMYP 20221-2025 101
4.3.1 Vaccines and Injection Equipment 101
4.3.2 Personnel Costs (EPI specific and shared) 101
4.3.3 Cold Chain Equipment Procurement and Maintenance 101
4.3.4 Operational Costs for Campaigns 101
4.3.5. Financial Sustainability 103
Chapter Five - Implementation, Monitoring and Evaluation 104
5.1 Implementation 104
5.2 Monitoring and Evaluation 104
Refrences 108
List of Figures
Table 2. Administrative vaccination coverage of Penta 3 and MCV1 by region, cMYP EFY 2008 10
to 2012
Table 3. Immunization coverage for selected antigens and dropout by region, Ethiopia EMDHS 11
2019
Table 7. Summary of AFP surveillance indicators in Ethiopia, 2016-2020 (Source EPHI VPD 22
weekly update)
Table 10. Measles Incidence Rate by Region, Ethiopia, comparison between 2018 & 2020 24
Table 11. Rota Virus Positivity Rate, sentinel surveillance indicators, 2015-2020, Ethiopia 29
In spite of the gains made during the previous multi-year plans, several challenges in the delivery of EPI services
including the COVID-19 global pandemic need a collaborative effort of all stakeholders to sustain the previous
gains and optimally reaching zero doses children, under vaccinated children and missed communities.
The current cMYP (2021-2025) document has strategies conforming to the vision of the global Immunization
Agenda/IA2030/ which envisioned as “a country where everyone, everywhere, at any age should fully benefit
from all vaccines for good health and well-being”.
The Ministry of Health would therefore like to express its special thanks for the tireless efforts of the technical
team supporting the National Immunization program for the successful preparation of the document in the
shortest possible time. Our appreciation goes also to those partners for their financial as well as technical
support without which it would have not been possible to prepare this document.
A thorough situation analysis, comprehensive EPI and surveillance review conducted in 2018 provided useful
information on best practices, weaknesses, opportunities, and lessons learned over the previous years that
formed the basis for development of this cMYP (2021-2025). The current cMYP(2021-2025) document preparation
process has taken in to account the Governments’ second Health Sector Transformation Plan/HSTP II/, experience
gained during the past years of implementing routine and supplemental immunization activities, new vaccine
introduction and the global Immunization agenda 2030/IA2030/, GAVI 5.0, and WHO technical immunization
guidelines for program use at all levels.
Establishment of the structures for immunization program management at the national and regional levels; all
vaccines, injection materials and equipment used at all levels conform to WHO standards/specification and
strong support and collaboration from Development Partners for EPI.
The process of development of the new comprehensive multi-year plan for 2020-2025, has accorded the
stakeholders and partners an opportunity to reorganize approaches to address the current/future challenges and
to explore opportunities for more effective and efficient delivery of services.
Focus will be made to improve immunization coverage through reaching all un-immunized and under immunized
children in every district/Woreda/community; introduction of new and underused vaccines like Hepatitis B birth
dose, Yellow fever, MenA etc. and maintaining a high quality and sensitive disease surveillance system at all
levels in order to detect and respond timely to any Vaccine Preventable Diseases outbreaks.
Lastly, the Maternal and Child Health Directorate pledge full commitment in implementation of the plan and
look forward to attainment of the set objectives and targets. The directorate would also like to express its
appreciation for the unreserved efforts of the EPI case team, other Directorates of the FMoH, EPI stakeholders
and partners for their invaluable contributions.
The comprehensive multiyear plan (cMYP) is the through time-tested mechanisms such as annual EPI
medium term or strategic plan for the Expanded review meeting.
programme on Immunization (EPI) in Ethiopia,
prepared in consonance with the 5 year strategic The role of the ICC in ensuring that the plan is on the
plan of the health sector for the year 2021 to 2025. proper track. It is expected that this national plan
will serve as a guide and template for regional and
The goals of the cMYP are: district annual plans during 2021-2025.
■ Reduce morbidity and mortality from vaccine- The current plan is presented in five chapters
preventable diseases for everyone through the described briefly as below:
life course.
Chapter One: Country Information
■ Leave no one behind by increasing universal This describes the country profile and demographic
and equitable access and use of new and information, administration and politics, the
existing vaccines. macroeconomic environment, the health status, and
■ Ensure good health and wellbeing for everyone the Expanded Programme on Immunization (EPI) in
by strengthening immunization within primary Ethiopia.
health care and contribute to universal health Chapter Two: Situation Analysis
coverage and sustainable development.
This chapter provides information on the current
■ Achieve vaccine-preventable diseases issues and challenges of the immunization
elimination and eradication goals. programme in Ethiopia. It further provides detail
description of the strengths and weaknesses of all
This strategic plan will be guided by the the components of the immunization system in the
above goals and consistent with the goals of country.
immunization agenda 2030.
Chapter Three: Goals, Objectives, Key
There are enabling and impeding factors that affect Activities, Indicators and Milestones
the effective implementation of all components of This chapter focuses on the goals and objectives of
the immunization system in the country. Improved the cMYP for each of the strategic components, key
access and quality immunization services have been activities, indicators, and milestones.
major challenges because of difficult topography
in the most hard‐to-reach areas and resource Chapter Four: Costing, Financing and
constraints. Despite these challenges there is Financial Gaps
government commitment, dedicated service staff This chapter elaborates on the plans for financing
and effective collaboration from partners like GAVI, and sustainability of the plan.
WHO, and UNICEF and so on to support and provide
immunization services. Chapter Five: Monitoring, Evaluation and
Implementation
Great amount of work has been done for developing This is the final chapter describing the monitoring
the cMYP starting from the situational analysis to and evaluation mechanisms which are put in place
costing, monitoring and evaluation. The progress to ensure effective and efficient implementation of
of implementation of the cMYP will be monitored the plan.
1.1 Governance and demography Regional States (NRSs), also called Regions (ክልል/
Kilile) and two city administrative councils under a
Ethiopia is the second most populous country in constitutional federal system. The regions and city
Africa, with a unique cultural heritage, diverse administrations are further divided into 108 Zones,
population, mixed ethnicity, and different religions. 1054 Districts and 32,000 urban dwellers and
Administratively, Ethiopia comprises of 10 National farmers association commonly known as ‘kebeles’.
According to projections from the 2007 National fertility rate of 4.6 births per woman (2.3 urban and
Census, the estimated total population for the year 5.2 rural) and a corresponding crude birth rate of 32
2020 is about 101 million in Ethiopia, ranking as per 1000 in 2016. As demonstrated in the contrasting
second in Africa and 12th in the world. Ethiopia is population pyramids for 2020-2029 shown below
home to more than 80 ethnic groups with the same (Fig. 2), the younger population will keep growing in
number of languages and dialects. The population the next decade.
is characterized by a rapid growth (2.6%), high total
Population structures by age and sex (Percent)
2020 2029
HSTP II Master file 2019-12-30 HSTP II Master file 2019-12-30
80+ 80+
Male Female Male Female
75-79 75-79
70-74 70-74
65-69 65-69
60-64 60-64
55-59 55-59
50-54 50-54
45-49 45-49
40-44 40-44
35-39 35-39
30-34 30-34
25-29 25-29
20-24 20-24
15-19 15-19
10-14 10-14
5-9 5-9
0-4 0-4
6 4 2 0 2 4 6 6 4 2 0 2 4 6
Specialized Hospital
3.5-5.0 Million Tertiary level health care
General hospital
Secondary level health care
(1-1.5 million) People
Primary hospital
(60,000-100,000) People
Health Center
Health center Primary level
40,000 (15,000-25,000) People health care
People
Health Post
(3,000-5,000) People
URBAN RURAL
As illustrated in Fig. 3, the primary health care unit or tertiary health care system consisting specialized
(PHCU) consists of health posts at the community hospitals that serves as a referral center for general
level, health center, and primary hospital. One hospitals and as training centers for medical doctors
health center is attached to five-satellite health and specialists. Furthermore, private health care
posts, aimed to provide services to a population facilities at different levels supplement the overall
of approximately 25,000. Health centers provide health care delivery.
both preventive and curative services and serve as
referral centers for health posts and as practical Regional Health Bureaus (RHB), Zonal Health
training sites for Health Extension Workers Departments (ZHD) and Woreda Health Offices
(HEW). Primary hospitals are organized to provide (WoHOs) provide a coordinated health management
ambulatory, inpatient, and emergency surgical and leadership services at their respective levels.
services to approximately 100,000 populations. The decision-making process is decentralized from
the regions and down to the district level (PHCU
At the second tier, general hospitals are organized level). According to FMOH 2018/19 report, there
to provide curative health services and serve as a are 338 hospitals, 4,063 Health Centers and 17,574
referral center for primary hospitals. It also plays Health Posts, which the latter is staffed by 42,000
vital role in the training of health officers, nurses, and Health Extension Workers (HEWs).
emergency surgeons. At the third tier is the highest
1.6 Rationale for the development of years in alignment with the national immunization
new cMYP (2021-2025) program goals and objectives along with the second
Health Sector Transformation Plan (HSTP II) and in
The cMYP of the EPI program is a key strategic reference to the global strategic frameworks such
and management document covering the next five as Immunization Agenda 2030 and the Gavi 5.0.
In this section the immunization performance Increasing health infrastructure and human
situation over the previous five years (2016-2020) of resources over the past five years has also made an
multi-year plan is analysed focusing on immunization impact to improve access to quality immunization
system components of: services and increasing vaccine management and
storage capacity by installing significant number of
i. Service delivery
SDD refrigerators.
ii. Surveillance
2.2. National Immunization
iii. Vaccine supply and quality
Implementation Guideline
iv. Logistics
The Ethiopian immunization policy implementation
v. Communication/social mobilization and guideline was developed in 2004 and it has been
vi. Program management, capacity building and revised in 2015 and 2019. The revised immunization
finance. policy implementation guideline (2019) highlighted
the second year of life immunization platform and
2.1 Expanded Programme on adolescent girl vaccination from the introduction
Immunization in Ethiopia of measles second doses (MCV2) and human
In Ethiopia, the EPI programme was launched in 1980 papillomavirus vaccine (HPV) into the routine
with the objective of reaching universal coverage to immunization program. Children of the under-one
all children under 2 years of age by 1990, with a year of age, the second year of life, adolescent girls (9-
14 years) and women of reproductive age group (15-
review of the policy to reduce overage to 75% and
49 years) are the targets for the currently available
reduce target age of children to under one year old.
vaccines in the immunization program of Ethiopia
The Reaching Every Districts (RED) and Sustainable (BCG, Measles, DPT-HepB-Hib or Pentavalent,
Outreach Services (SOS) approaches were Rotavirus Vaccine, Pneumococcus vaccine (PCV),
introduced in 2003. As part of an effort in addressing OPV, IPV, HPV and Tetanus diphtheria(Td) vaccine).
the immunization inequity and increase coverage,
the Periodic Intensification of Routine Immunization The country’s immunization schedule for the
(PIRI) has been implemented since 2018 in selected below-listed vaccines strictly follows the WHO
poor-performing woredas of agrarian and pastoral recommendations for developing countries.
regions. Other strategies to increase immunization Although no booster doses recommended in routine
EPI for childhood immunization, there are periodical
coverage have also been implemented including
supplemental doses for measles and polio.
Child Health Day events, intensified outreaches, and
pulse campaigns.
2.3 Immunization Service Delivery 2.3.2 Achievements of Child, Infant and Neonatal
Mortality Reduction
2.3.1 Implementation of cMYP 2016 -2020
There has been significant reduction in infant (IMR)
The 2016-2020 cMYP aimed to achieve the national and under 5 (U5MR) mortality rates during the last
and sub national vaccination coverage targets set at two decades, shown in Fig. 6 below, and largely
HSTP I, a polio-free status, eliminate measles, and believed that increased access to immunization
MNT, introduce new vaccines IPV, MCV2, MR, Men and introduction of new vaccine has significantly
A, HPV and Yellow Fever in line with the GVAP goals contributed.
and improvement of vaccine supply management
and cold chain capacity at all levels.
100 123 88
67
59
77 48 59
50
29 47
39 37 33
0
2005 EDHS 2011 EDHS 2016 EDHS 2019 EMDHS
2.3.3 Performance of Routine Immunization during and Benishangul-Gumuz regions were relatively
EFY 2008-2012 (2016-2020) consistent by different data sources. The most
recent Penta 3 and MCV1 administrative coverage
Immunization performance assessed by Penta 3 estimates for EFY 2012 (2019/2020) showed 97%
and MCV1 coverage as indicators for the period and 93% respectively, with large variations between
2008-2012/2016-2020 shows that coverage was regions where coverage for Afar, Somali, and Dire
maintained at 95% for Penta 3 and 90% for MCV1 Dawa was 70-80% while Amhara, Gambella and
with uneven coverage levels among regions. Tigray achieved between 80-90%. Coverage for
Administrative coverage was higher in Addis Ababa, Addis Ababa, Benishangul-Gumuz, Oromia, Harari
Harari, Oromia and SNNP while data from Somali, and SNPPR regions remained high at more than
Afar and Gambella was low. The estimates in both 90% coverage. MCV1, follow similar pattern with
directions were inconsistent with what was shown Penta 3 with slight variations (Table 2).
by survey estimates. Coverage for Amhara, Tigray
Penta3 MCV1 Penta3 MCV1 Penta3 MCV1 Penta3 MCV1 Penta3 MCV1
Addis Ababa 100% 100% 100% 85% 100% 85% 154% 145% 108% 146%
Afar 100% 94% 92% 88% 82% 69% 74% 67% 74% 72%
Amhara 92% 90% 93% 90% 93% 89% 88% 84% 87% 88%
B. Gumez 99% 93% 100% 96% 97% 93% 89% 84% 90% 85%
Dire Dewa 79% 78% 78% 76% 86% 79% 79% 71% 78% 72%
Gambella 77% 61% 85% 76% 85% 74% 88% 78% 85% 70%
Haraeri 100% 92% 100% 93% 100% 100% 111% 100% 111% 98%
Oromia 100% 99% 100% 97% 97% 93% 105% 96% 104% 99%
SNNP 99% 97% 100% 97% 96% 93% 75% 93% 100% 73%
Somali 76% 71% 80% 75% 77% 71% 80% 69% 78% 91%
Tigray 89% 86% 78% 85% 91% 85% 89% 85% 89% 86%
National 98% 94% 97% 94% 96% 90% 96% 90% 97% 93%
2.3.4 Immunization data quality four transformation agendas stipulated in the HSTP
I and HSTP II. The agenda embraces data generation
Immunization data in Ethiopia varies greatly by and digitalization, staff capacity building, motivation
sources such as administrative, WUENIC, and and practice in data management including analysis
surveys largely due to differences in methodology and data use for action. The overall discrepancy
in data collection, use of inaccurate and dissimilar where Penta 3 and MCV1 coverage estimates by
denominators, inadequacy in recording, and administrative, WUENIC and surveys between
reporting. The problem is so chronic and deep 2000-2019 is shown in Figures 2 and 3 below.
rooted that “information revolution” is one of the
100 96 96 96 95 96
90 86 87 87
81 83 82
79
80 73
72 73 73 73 72
69 69
70 66 65
61 62 61
58 59
% Coverage
60 56.3 54
51 51 52 66 60.9
50 59.5
50 44 46
42 53.2
40
40 35 37
32 30 36.5
30
31.9
20
20.7
10
0
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Year
Figure 2. 3 Trends of Penta 3 coverage by different data sources from 2000 to 2019
Comprehensive Multi-Year Plan (2021-2025) 9
100 92 93 92 91
88
90 82 84
81 80
75 76
80 74
% Coverage
68 65 66 65
70 65 64 62
63 59 61
56 59 55 58
60 54 54
51.9 49
50 44 44
42 40
40
37 37 55.7 68.2 54.3 58.6
35 35
30 35 36 36
34.9 54.3
20
26.6
10
0
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Year
Survey EDHS Mini-DHS WUENIC Admin
Table 3. Immunization coverage for selected antigens and dropout by region, Ethiopia EMDHS 2019
Region Penta 1 Penta 3 MCV1 MCV2 DOR Penta DOR All Never been
1-3 Penta types of vaccinated
1-MCV1 vaccines
Addis Ababa 96.3 93.1 90.6 3.3 3 6 83.3 3.7
Afar 45.5 25.9 28.5 8.5 43 37 19.8 44.9
Amhara 84.4 80.2 71.3 13.3 5 16 62.1 14.8
B./Gumuz 89.2 81.2 77.4 1.6 9 13 66.7 9.8w
Dire Dawa 95.2 74.2 74.2 17.7 22 22 53 2.6
Gambella 76.3 65 57.6 21.2 15 25 38.3 14.2
Harari 65.3 52.8 58.7 7 19 10 45.8 20.4
Oromia 73.4 53.6 48.7 5.2 27 34 29.9 18.9
SNNP 72.7 50.8 58.2 15.3 30 20 38 24.2
Somali 42.2 26.2 31.1 1.4 38 26 18.2 48.8
Tigray 95.4 84.4 82.9 17.2 12 13 73 4.6
National 76.3 60.9 58.6 9.1 20.2 23.2 43.1 19.2
Number of Oromia Amhara SNNPR Somali Tigray AA Afar BG Dire Dawa Gambela Harari National
Unimmunized
(mini-EDHS 2019) 569,705 136,824 322,566 134,383 27,836 5,689 38,985 6,578 3,965 4,688 3,599 1,254,810
Similarly, marked differences of MCV1 coverage regional, and global targets as disparities across
and dropout rates between Zones and Districts geographic areas and population groups continue
indicating the build-up of unprotected children with to prevail. EDHS survey findings and recent inequity
potentials of increased risk for measles outbreaks assessment by UNICEF identified geographic
and jeopardizing the measles elimination goals. The area (pastoralist), household wealth, caregivers’
introduction of MCV2 and the extension services to education, and place of residence (urban) as
second year of life is hoped to improve coverage of determinants influencing access to and utilization of
not only MCV but also of other antigens. Coverage immunization services3. Details are shown on Fig.
has increased steadily but has not met national, 8 below.
Ethiopia (DHS2000-2019) Immunization Inequity Trend
48.0
40 35.5
39.9
33.8
38.0
34.3 33.7 34.1 36.7
28.0 29.8
20 22.3 2. Penta 3
16.3 15.8
46.7
40.8
40 34.4
40.7 39.6
33.4 33.2
31.1 32.2 30.6
27.6 27.8 28.1
20
24.5 3. Measles
40.8 41.1
40 33.7
40.0
34.8 36.9
31.3 31.0 31.4 29.5
27.7
20 21.5 24.3
20.4 4. Fully Vaccinate
40
29.8
23.7
20 16.3 16.0
19.6 18.1 5. No Vaccine
12.8 13.6 13.3 13.8 13.6 13.6
11.1 9.8
0
2000 2005 2011 2016 2019 2000 2005 2011 2016 2019 2000 2005 2011 2016 2019
Immunization coverage in equality in children 12-23 months old by wealth, education and residence
70
70 69 69
62
60 56 56
55 54 54
50
43 42
40 39
35 35
30 29 29
20
20
10 7
0
Tigray Afar Amhara Oromiya Somali B/Gumuz SNNPR Gambela Harari Addis Dire dawa
Ababa
Regions
Figure 2. 5 Proportion of incomplete immunization for the three EDHS periods Melaku et.al BMC
2.3.5 Routine Immunization Service Provision According to Service Availability and Readiness
Platforms and Strategies Assessment (SARA) 2018, about 81% of health
facilities offer child immunization services ranging
In Ethiopia, routine immunization service is available from 17% in Addis Ababa and 88% in Oromia
at almost all government health facilities through Region. MOH administrative data report (2012 EFY),
one or a combination of static, outreach, and has shown that 67.1% children received vaccination
mobile (extended outreach) strategies depending from health posts while 28.4% and 4.4% of
on the distance between the health facility and children received from health centres and hospitals
community’s settlement. respectively. Immunization services is by and large
16
2016 2017 2019 2020
No REGION 1ST Round SIAs 2ND Round SIAs 1ST Round SIAs 2nd Round SIAs 1st Round SIAs 2nd Round SIAs 3rd Round SIAs Vaccinated %
2 Oromia 2,531,921 105.9 2,460,982 103 2,795,361 114 2,531,385 104 1,450,642 103 1,473,317 103 2,666,079 104
3 SNNPR 252,012 105.3 251,381 100 259515 103 267,046 106 274,064 101
5 Gambella 101,724 94.5 114,846 100 116,601 97 126,103 98 142,794 103 144,528 96 147,655 99
8 Dire Dawa 59,516 97.2 60,791 99 60,698 103 63,564 104 72,184 114
10 Addis Ababa
11 Somali 1001325 96.3 1,022,712, 98 1,062,709 98 1,056,775 98 1,176,428 99 1,163,897 98 1,230,955 99 1,414,120 100%
Total 5,019,375 101.6 4,959,135 100 5,357,999 106 5,111,635 102 2,769,865 101 2,781,742 100 5,482,337 101 1,414,120 100%
Remark: Target for 2019 in 1st and 2nd rounds was 19% of the national target
1 Round SIA
ST
2 Round SIA
ND
1 Round SIA
ST
2 Round SIA
nd
2 Round SIA
nd
Total 497,953 99 509,049 102 1,995,915 104 588,839 100 1,764,518 108
100%
7% 7% 7% 8% 8% 8% 7% 7% 6% 5% 5%
17%
38%
75% 47% 45%
41% 39% 40% 46% 65%
30 % 46% 43% 46% 47% 46%
58%
12 %
50% 5% 6% 4%
Percent
25% 50% 49% 49% 49% 46% 49% 47% 52% 55% 54% 49%
45% 46%
34% 30%
0%
2022(0)
2021(1)
2020(2)
2019(3)
2018(4)
2017(5)
2016(6)
2015(7)
2014(8)
2013(9)
2012(10)
2011(11)
2010(12)
2009(13)
2008(14)
Birth Year (age)
Figure 2.6 Measles immunity profile for population ≤19 years, Ethiopia, 2020.
The planned measles follow up SIA for 9-59 months by undertaking all the necessary precautions to
old children in April 2020 was postponed to July prevent further spread of COVID-19 during the
2020 because of the COVID-19 pandemic. Because campaign. This most recent campaign achieved
of the continued progressive measles outbreaks 97% administrative coverage.
in many parts of the country, the MOH decided to
conduct the measles vaccination campaign during
the early transmission of COVID-19 in the country
Ethiopia is now planning for a measles SIA in is believed to be prevalent in pocket areas of the
2022 targeting all children 9-59 months old and country due to low routine tetanus toxoid vaccination
implementing innovative strategies to reach zero- coverage coupled with the high number of deliveries
dose and under-immunized children. handled by untrained personnel. In an effort to
sustain MNTE, Ethiopia developed sustaining
2.3.14 Maternal and Neonatal Tetanus SIAs strategies including:
Ethiopia was declared free of Maternal and Neonatal 1. Reduce to less than one case of neonatal
Tetanus by the WHO and UNICEF expert validators tetanus per 1,000 live births by 2010,
in June 2017 and it is a significant achievement
2. Increase Penta 3 coverage >80% in all woredas,
for the country. However, Neonatal Tetanus death
Table 7. Summary of AFP surveillance indicators in Ethiopia, 2016-2020 (Source EPHI VPD weekly update)
NP-AFP rate per 100,000 < 15 Yrs. 2.0 3.1 2.5 2.3 2.6 2.5
Stool adequacy 80% 91% 92% 93% 90% 90%
Timelines and completeness of reporting 80% - 86.2% 89.6% 89.12% 90.2%
of priority diseases
90% 88.4% 93.1% 93.4% 91.7%
Investigated < 2 days of notification 80% 93% 92% 93% 89% -
Specimen arriving at lab < 3 days 80% 99% 99% 99% 98% 79.8%
Specimen arriving in good condition 90% 85% 92% 89% 95% 98%
Non-polio enterovirus isolation rate 10% 9.10 7.20 7.00 3.90 6.8
Timely Lab result within 14 days of receipt 80% 89% 90% 91% 90% 67.4%
Table 8. Measles case-based surveillance performance indicators, 2010-2020 (Source: measles surveillance update 2020)
In 2020, a total of 1503 confirmed measles outbreaks measles outbreaks in 2020 compared to 125 in 2019,
were reported compared to 2255 in 2019 and 1204 and 55 in 2018. (see Table 7).
in 2018. A total of 108 woredas were affected by
Indicators 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
#of Measles 76 60 196 146 243 293 128 67 55 142 112
Outbreak
#of Woredas 59 51 143 125 192 242 113 61 55 125 108
Affected with
Measles Outbreaks
#Igm + cases from 309 248 945 623 1402 1567 690 315 241 792 531
the Outbreak
#EPI-linked cases 3092 1530 2582 3178 3982 9054 2159 1194 963 1363 972
#Total Confirmed 3201 1776 3527 3801 5384 10,621 2849 1509 1204 2155 1503
Outbreak cases
The measles incidence rate in the country used to be 20 per million population per year in Tigray to 76
varied from year to year, mainly affected by measles per million population per year in SNNPR and Addis
SIAs (Table). Measles incidence in 2019 was Ababa (Table 8). There is also wide variation in the
reported to be 40 per million population per year, measles incidence among zones (Fig. 10).
with wide variation among regions, ranging from
Table 10. Measles Incidence Rate by Region, Ethiopia, comparison between 2018 & 2020
1600
1510
1400 50
46
45
1200
40
1000 35
781 30 28
800 736
25 23
21
600
20
457
400 15
277 10
10
200 114
5
0 0
Oromia SNNPR Amhara Somali Addis Tigray Hareri D. Dawa Gambela B. Gumuz Afar
Figure 2. 7 Comparison of Confirmed Measles Cases by High and Low Contributing Regions, Ethiopia, Jan-Dec 2019
Larger proportion of measles cases occur in the gradual increase in the proportion of measles cases
age group below five years, though there has been in adults as shown in Fig. 12 below.
<5 5 to 10 11 to 15 >15
100
90 17% 16% 16% 15% 22%
25% 20% 27% 27%
80 11 % 41%
43%
Confirmed Measles Cases
n= 6196 4515 4619 6539 13311 17745 4579 1921 1512 3998 1944
700
652
600
No. of Rubella IgM+
500
400
329
310
300 266
213
200 174 184
130
95
100
0
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Year
Children of age below 10 years account for majority geographic distribution of confirmed Rubella cases
(84%) of the confirmed Rubella cases. The age and is indicated in Figs 14.
<5 5 to 10 11 to 15 >15
100% 0%
0% 0% 7% 0% 7%
12% 13% 14%
90% 7% 12%
33% 13%
80% 40% 14%
47 %
70%
0% 36%
44%
% Rubella Caases
0% 0% 11%
Addis Ababa Afar Amhara B. Gumuz Gambela Oromia SNNPR Somali Tigray National
n= 31 3 10 5 5 16 16 7 2 95
Figure 2.10 Age distribution of Confirmed Rubella Cases by Region, Ethiopia, Jan to Dec 2020
1200
1000
800
cases
Figure 2.11: Number of Suspected Pediatrics Bacterial Meningitis Cases per Year from 2015-2020
20
Number of Culture Confirmed PBM Cases
18
16
14
12
10 Nm
8 Spn
6 Hib
4
2
0
2015 2016 2017 2018 2019 2020
Year
Figure 2.12 Etiologies identified for PBM, 2015-2020, Ethiopia;
Figure 2. 12 Etiologies identified for PBM, 2015-2020, Ethiopia;
Note: etiologies areStreptococcus
Note: etiologies are HiB, HiB, Streptococcus pneumoniae
pneumoniae (Spn) and (Spn) andMeningitides
Neisseria Neisseria Meningitides
(Nm) (Nm)
Table 11. Rota Virus Positivity Rate, sentinel surveillance indicators, 2015-2020, Ethiopia
90%
60% 51%
57% 60% 57% 58%
56%
50%
40%
30%
20%
10%
0%
Composite E1 E2 E3 E4 E5 E6 E7 E8 E9
evm_2013 evm_2019
Figure 2. 13 Assessment results EVMA 2013 & 2019 – Composite and Criteria score
Figure 35 below shows the performance by supply points (Woreda) and there is decline at service points
chain level for the two assessments conducted in (Health Facility) from 71% to 65%. Comparison of
2013 and 2019. The 2019 result shows that there the criteria scores for 2013 and 2019 assessments
has been an improvement in the composite scores at national and sub national levels shows significant
at the primary store (National) from 60% to 78% and improvement as the level progresses in all the
Sub-national level (Hub) from 64% to 74%, whereas criteria whereas the opposite is true for the Woreda
there is no change (63%) at the lowest distribution and health facility levels.
90% evm_2019
80%
78%
74%
71%
70% 70%
50%
40%
30%
20%
10%
0%
Composite Score EPSA Hub Woreda HF
Figure 2. 14 EVM performance per supply chain level for 2013 and 2019
40%
63%
E2: Temperature
90%
80%
90%
70% E3: Storage capacity
59% 60%
E9: IMS, supportive 50%
functions 40%
30%
20%
10% 82%
84% 0% E4: Buildings, equipment
E8: Vaccine & transport
management
77%
E7: Distribution 72%
E5: Maintenance
77% 0% 71%
E8: Vaccine E4: Buildings,
management equipment…
65% 51%
E5:
E7:
Distribution Maintenance
HFHFlevel
levelEVMA
EVMA 2019
2019result
result
70%
E2: Temperature
45%
100% 76%
E9: IMS, supportive
functions 80% E3: Storage capacity
60%
40%
20% 74%
82%
E4: Buildings,
E8: Vaccine equipment & transport
management 0%
59% 56%
E7: Distribution
E5: Maintenance
Figure 2. 15 EVMA performance in supply chain level by EVM criteria 2019 EVMA
Since in 2013, the country procured and installed National Cold Chain Equipment Inventory
61 Cold rooms, 2 freezers were installed and as a
result cold storage capacity increased from 1,300 in National cold chain equipment inventory (CCEI) was
2013 to 4,248 cubic meters. In the last five years, conducted in 2020 with the objective of quantifying
over 27 cold rooms were regularly maintained (both and characterizing their variety, capacity and
corrective and preventive) at different hubs. Five functional status among HPs, HCs, Hospitals, and
new cold room’s installation at different EPSA hubs: administrative units throughout the country. The
(AA-Hana Mariam (2), AA- Jackros (1) Semera (1) survey also aimed to evaluate the cold chain storage
& Assosa (1) in 2019 as a result of new five cold capacity and distribution by the level in the health
room installation cold storage volume increased by system as well as to identify immediate and long-
462M3 gross. Re-location of cold rooms from RHB/ term requirements thereby meeting future EPI needs
Zonal HO to EPSA compound made in five sites According the CCEI survey data:
(Diredawa, Semera, Dessie, Nekemte & Assosa).
A total of 20,765refrigerators and freezers were
Monitoring of cold rooms temperature through found at 20, 797 different levels of the health
installing of Remote Temperature Monitoring structure from all regions of Ethiopia, summarized
devices (RTMDs) is being conducted to all EPSA as follows;
hubs, (except Negele hub). In addition, temperature
monitoring devices with GPS to monitor the
■ From the total 40,593 passive containers ■ From the total of 20,765 equipment
inventoried, 27,029 are vaccine carriers (VC) inventoried, 13,170 (63.4%) were functional,
and 13,564 cold boxes (CB) 6204 (29.9%) nonfunctional due to variety of
reasons, 836 (4.0%) obsolete and 555 (2.7%)
■ The national average of health facilities
uninstalled.
(hospitals and health centres) with functional
incinerators was reported to be only 26%
Reason for non-functionality includes lack of spare part, power supply, lack of technicians etc.
2.5.3. Vaccine Direct Delivery Three EPSA hubs (Bahir Dar, Jimma and Mekele)
were selected to begin the transition by taking over
Since the beginning of the transition in 2014, EPSA storage and distribution of vaccines from RHBs and
has been engaged in a number of activities to ZHDs, and scaling up delivery to zones from all other
operationalize the transition of vaccines including hubs by 2015. The second phase was to bypass all
updating LMIS, carrying out system design and ZHDs and deliver vaccines from all EPSA hubs to
delivering vaccines directly to Woredas and Health Woreda Health Offices (WoHOs) by end of 2016. The
facilities. In addition, 20 refrigerated trucks were third phase which is currently under implementation
procured and deployed to the 17 ESPA hubs to is delivering vaccines to all WoHOs and accessible
increase the efficiency of vaccine distribution to the health facilities. The final phase is direct delivery to
last mile health facilities by bypassing WoHOs.
Somali
Tigray
Dire Dawa
Sidama
Harari
Addis Ababa
Afar
Gambella
Amhara
Oromia
Benishangul
1 2 3 4 5 6 7 8 9 10 11 12
# of puplic health facilities # of Direct delivery to Health Facilities
2.5.4 Injection safety and waste disposal ■ Auto-disable (AD) syringes are the preferred
type of injection equipment for administering
Injection safety is the safe handling of all injection vaccines. These are also used once and cannot
equipment, routine monitoring of the availability be re-used, because the plunger of the syringe
and use of safe injection equipment, and correct cannot be pulled back again once it has been
disposal of contaminated injection equipment. pushed forward to inject the vaccine.
A safe injection is one that results in no harm to
the recipient, the vaccinator, and the surrounding In addition, leak proof boxes are specifically designed
community. Starting from 2002 Ethiopia uses. to receive syringes with their needles attached
with minimal capacity of 100 syringes and should
■ Disposable, sterile, single-use syringes, and not be reused. The recommended waste disposal
needles, which are used once only and then method is incineration in all health facilities using
disposed of safely. They are used for mixing incinerators. However, burning and burial is also
freeze-dried vaccines (BCG and measles) with used in health facilities. Waste disposal for mOPV2
their diluents and will never be re-used. vaccine is centralized. mOPV2 is a vaccine used for
Although there were some studies available around ■ Absence of immunization communication officer
behavioral aspect of immunization practices during at regional/zonal and woreda levels
last cMYP, there is still limited evidence around
demand generation activities. Majority of the studies ■ Weak integration of communication activities
applied quantitative methodologies at regional with HEWs activities in some areas
or national level with limited focus on qualitative ■ Limited dedicated budget for demand
insight. Given the ethno-linguistic diversity of generation, communication and social
Ethiopia, there is a need to conduct behavior and mobilization interventions
social drivers around immunization practices in a
■ Limited researches that evaluate/assess social
contextualized manner.
and behavioural aspects of immunization
practices
2.6.3.2 Risk Communication
■ Though there is structure in some places
Risk /crisis communication includes the range of women development army is not functional in
communication capacities required through the some places , dissolving in some woreda/zones
preparedness, response and recovery phases of a ■ Increasing vaccine hesitancy among parents to
serious public health event to encourage informed bring children for immunization services
decision making, positive behavior change and the
■ Repeated interruption of pregnant women
maintenance of trust.
conferences
Ethiopia needs to develop locally-relevant ■ Decreasing commitment (increasing burnout)of
communication strategies for rapid response to health care providers including health extension
public concerns, including those relating to AEFI. workers
Whether a public concern reveals an underlying
Table: Budget Support from selected EPI Partners in the last 5 years
The GAVI fund has brought a significant contribution by GAVI in Ethiopia for two subsequent years. GAVI
for strengthening immunization systems to CSO Support fund has learned partnership and
sustainably and equitably increase immunization networking among government agencies, PVOs/
coverage to meet national standards through PIRI NGOs, and community was vital to reach the
operationalization. Civil Society Organization (CSO) unreached communities and to avoid duplication of
support was also one of the few pilot areas provided efforts.
Immunization ■ Coverage of antigens is increasing over time ■ Coverage is not at optimal level.
Service Delivery ■ Immunization System/structure available to ■ High dropouts and disparity persists among regions and
service delivery and the community level Woredas (wide equity gap by administrative localities,
■ The immunization service was provided residence, education, and wealth).
amid of COVID-19 pandemic and the impact ■ Weak integration of Immunization services with other
of pandemic was not significant Maternal, Neonatal and Child health and nutrition services
■ HPV introduced expanding age groups to leading to missed opportunities
immunization. ■ Interruption of vaccination sessions both in outreach and
■ Successful switch of vaccines PCV 10 to PCV static
13 and TT to TD ■ Interruptions of PIRI service due to funding gaps
■ Post Introduction Evaluation for newly ■ Some Health facilities not providing vaccination service
introduced vaccines ■ Lack of strategies to track and vaccinate mobile community
■ Conducting successful SIAs ■ Sub-optimal quality of EPI service provision, including age
■ Implementing cVDPV2 outbreak response invalid doses, particularly for MCV.
SIAs ■ Delayed new vaccines introduction (Men A, YF, Hep BBD,
■ Conducted many follow up and catch-up MR).
measles SIAs with coverage of above 95% ■ Poor private health facility engagement
■ Persistently missed children in hard to reach, pastoralist
and urban settings
■ Inconsistency in immunization coverage data across
different data sources and poor use of data for decision
making
Surveillance ■ Established strong Case and lab-based AFP ■ Sub-national AFP and measles surveillance gaps.
surveillance since the adoption of the GPEI. ■ Persistently low detection of EIV in national polio lab.
■ Achieved and sustained interruption of ■ Measles elimination targets not on track.
WPV transmission since January 2014 and ■ Unable to achieve adequate population immunity for
certified as WPV free country since 2017. Measles. .
■ Achieved majority of the Measles ■ Delayed outbreak notification in some cases leading to
surveillance performance indicators. delayed responses.
■ Validated for elimination of MNT ■ Weak VPD risk assessment, EPRP process and
Immunization Supply ■ Adequate dry store for dry materials/ ■ Shortage of transport vehicle.
chain management consumables. ■ Delay of newly procured cold rooms installation,
■ The cold rooms are in good condition with ■ Lack of follow-up and monitoring of the written
functional standby generator, voltage maintenance plan implementation for cold chain
regulator and alarm systems and safety equipment.
cloths for central and most of the hubs. ■ Weak support (transport, budget, tool kits & monitoring)
■ Availability of continuous temperature utilization of the trained technicians (senior & mid-level)
monitoring system (central and hubs). ■ Lack of recording and reporting system for maintenance
■ Availability of distribution plan and a (CCE, including refrigerated trucks) activities
monitoring mechanism at the vaccine
storage facilities at national level.
51
52
EPI COMPONENT Strengths Weaknesses
Immunization Supply ■ Stock records designed to register wastage, ■ Poor spare parts management (planning, requesting,
chain management expire and heat exposure (VVM). (center and issuing and Stock management) - (Availability, storage and
hub) distribution).
■ Existence of legal framework, regulation and ■ There is no up-to-date/regular cold chain equipment
guidelines to monitor safety of medicines inventory system
and AEFI surveillances in the country ■ Irregularity in providing formal or on the job training for
■ Existence of national AEFI causality vaccine supply chain
assessment committee ■ Poor data quality and visibility at the lower level
■ Absence / turnover of trained cold chain technicians for
cold room maintenance and vaccine management at
national & EPSA at all levels
■ Poor implementation of annual work plan at all level
■ Poor vaccine stock management, no adherence to stock
level policy especially at woreda & health facility level
■ Absence of job aids (VVM& other CC PPM) & other training
manual related to vaccine supply chain management at
health facility level.
■ Lack of temperature monitoring/not using fridge tags/
freeze tag during transportation (if conditioning icepack
used).
Advocacy, ■ Revitalized the CTWG at National level ■ Poor leadership commitment at lower levels
communication& ■ High level Advocacies conducted at national ■ Inadequate Inter Personal Communication (IPC) skill among
Social mobilization and regional levels HCWs
and Risk ■ Averted disinformation, misconceptions and ■ Limited stakeholders engagement including CSOs at lower
communication rumours on HPV through extensive social level
mobilization and community conversations. ■ Extent of Immunization IEC materials utilization unknown
■ Availability of IEC materials, Brochures, job ■ No dedicated Communication HR structure at Subnational
aids with different languages level
■ Social mobilization & demand generation activities are
53
54
EPI COMPONENT Strengths Weaknesses
Program ■ Strong EPI Coordination mechanism at ■ Low quality micro-planning, RED/C implementations:
Management FMoH level (Existence of functional ICC, (missing minorities, remote areas, slum areas, urban
NITAG, EPI Taskforce & TWGs providing periphery).
oversight and technical guidance to EPI). ■ Poor EPI data quality management as evidenced by huge
■ Dedicated EPI unit at MOH level discrepancies between admin coverage and conventional
■ Existence and the practice of having cMYP, estimates like WUENIC estimates, EPI coverage survey and
EPI Annual Work Plan and Woreda Based EDHS survey results.
Plan. ■ No well-structured, data pool and proper documentation as
■ Presence of functional DHIS tool data repository/storehouse
■ Absence of use of process monitoring indicators (quality
services delivery, coverage triangulation, data quality
varication session interruptions)
■ Limited technology assisted data management, monitoring,
supervision (geocoding, data collection and analytical
software)
Strengthening ■ Posting EPI focal persons at regional and ■ Inadequate human resources for EPI
human and zonal levels ■ There is no platform to track trained HWs
institutional ■ Conduct Training to build the capacities and ■ Trainings were conducted without need assessment
resources skills of EPI service providers Various TAs ■ High staff turn overs
have posted to strengthen HR in different ■ Lack of incentives and motivation
regions ■ No functional posts for e EPI coordinators at regional, zonal
levels
■ Pre service Curricula lacks basic immunization education.
■ Inadequate capacity of institutions to conduct operational
research to generate evidences
Planning and coordination: The forward Public private partnership: The MOH will work
ambitious immunization strategic plan, the existing with private facilities that provide immunization by
and new coordination mechanisms like the ICC, the capacity building, ensuring quality of immunization,
taskforce, the technical working groups, and the cold chain standardization and reporting.
NITAG need to be strengthen at all levels.
COVID19 precaution and infection prevention:
Enhancing partnership and collaboration for While planning, implementing and close out of
immunization: Partnership and collaboration for vaccination sessions; ensure COVID19 prevention
immunization will be expanded within the country, precautions (physical distancing, one-way client
continental and international immunization partners. flow, ventilation, handwashing washing/sanitizer,
wear facemask and properly contain vaccine
Create demand, and gain/Sustain trust: wastes).
Development and implementation of integrated
communication plan for immunization and address
any mistrust among different interest group and
maintain the trust of the community.
64
Indicators Base year Expected Targets
coverage coverage
m-EDHS 2019
2019 2020 2021 2022 2023 2024 2025
Total Population 99,603,376 101,767,684 102,193,064 104,850,083 107,576,186 110,373,166 113,242,869
Live Births (3.36%) 3,346,673 3,419,394 3,433,687 3,522,963 3,614,560 3,708,538 3,804,960
Infants’ deaths (43/1000 4,282,945 4,274,243 4,189,916 4,194,003 4,195,471 4,194,180 4,076,743.28
in mini EDHS 2019
Surviving infants (3.16%) 3,147,467 3,215,859 3,229,301 3,313,263 3,399,407 3,487,792 3,578,475
12-23 months old (2.5%) 2,490,084 2,544,192 2,554,827 2,621,252 2,689,405 2,759,329 2,831,072
9-13 old female pop (7%) 6,972,236 7,123,738 7,153,514 7,339,506 7,530,333 7,726,122 7,927,001
Pregnant women (3.36%) 3,346,673 3,419,394 3,433,687 3,522,963 3,614,560 3,708,538 3,804,960
Target population BCG 2,443,072 2,667,127.46 3,055,981.38 3,205,896.15 3,397,686.25 3,560,196.86 3,728,861.18
BCG coverage 73% 78% 89% 91% 94% 96% 98%
Target population OPV3 1,888,480.01 2,154,625.41 2,615,733.66 2,816,273.24 3,025,472.64 3,208,768.69 3,399,550.92
OPV3 coverage 60% 67% 81% 85% 89% 92% 95%
Target IPV vaccinated 2,041,471 2,154,625.41 2,615,733.66 2,816,273.24 3,025,472.64 3,208,768.69 3,327,981.43
IPV Coverage 61.0% 67.0% 81% 85% 89% 92% 93%
Target population 1,919,955 2,154,625.41 2,615,733.66 2,816,273.24 3,025,472.64 3,208,768.69 3,399,550.92
Penta 3
Penta 3 coverage 61.0% 67.0% 81% 85% 89% 92% 95%
Target population 2392075 257268705 2874078 3015069 3195443 3348280 3506905
(Penta 1)
Penta 1 coverage 76 80 89% 91% 94% 96% 98%
65
66
Indicators Base year Expected Targets
coverage coverage
m-EDHS 2019
2019 2020 2021 2022 2023 2024 2025
Annual Penta Dropout 20.2 16 8 6 5 4 3
rate
Annual Measles Dropout 23.2 19 9 7 7 6 5
rate 1
Annual MCV1-MCV2 15 10 8 7 6 6
Dropout rate 1
Men A 0 0 - - 2,991,479 3,139,013 3,327,981
Men A Coverage 0 0 0% 0% 88% 90% 93%
Yellow Fever 0 0 0 2,650,610 2,889,496 3,139,013 3,327,981
Yellow Fever Coverage 0 0 0 80% 85% 90% 93%
HPV1Performance 1,147,431 1,172,364 1,177,264 1,220,455 1,252,187 1,297,988 1,331,736
HPV1 Coverage 96% 96% 97% 97% 98% 98%
HPV2 Performance - 1,013,606 1,071,801 1,117,282 1,164,405 1,207,924 1,304,558
HPV 2Coverage 83% 87% 89% 90% 91% 96%
Target Hep B Birth dose 14621 2924059 3108521 3300599 3500564
Coverage 80% 83% 86% 89% 92%
Target COVID 19 vaccine 0 0 20,438,613 52,425,042 16,136,428 11,037,317 5,662,143
Coverage from total 0 0 20% 50% 15% 10% 5%
population
Coverage from target 0 0 80% 85% 90% 93% 95%
Target fully Vaccinated 1,353,411 1,607,929 1,776,115 2,153,621 2,549,556 2,790,234 3,041,703
Fully vaccinated 43.0% 50.0% 55.0% 65.0% 75.0% 80.0% 85.0%
Global/ AFRO
NATIONAL PRIORITIES NIP OBJECTIVES NIP MILESTONES ORDER OF PRIORITY
REGIONAL GOALS
■ To vaccinate 89% of
Routine Immunization ■ To achieve 98% Penta 1 coverage nationally
children with Penta 1 in
Coverage and equity and 98% in every district by 2025.
2021; 91% in 2022; 94%
■ To achieve 95% Penta 3 coverage nationally
in 2023; 96% in 2024 and
■ Low coverage and 95% and above in every district by 2025.
98% in 2025
with high disparity ■ To achieve 93% MCV 1 coverage nationally
■ To vaccinate 81% of
among regions and and 88% and above in every district by 2025.
children with Penta 3 in
Woredas. (Penta To achieve 87% MCV 2 coverage nationally
67
68
SIAs and NIP OBJECTIVES NIP MILESTONES Global/ AFRO REGIONAL GOALS ORDER OF
Surveillance PRIORITY
Polio Preventive ■ Achieve >95% SIAs coverage in ■ Two rounds SIA annually with ■ Interrupt transmission of all One
and outbreak all districts all through 2024 coverage >95%. wild polioviruses ( WPV).
response SIAs ■ Achieve and maintain the ■ Mobilize additional funds to ■ Ensure sensitive
function and polio free status ■ bridge funding gaps poliovirus surveillance
mistermed in to national ■ Monitor quality of SIAs through integration
immunization system ■ Receive polio funded assets with comprehensive
phase by phase, vaccinepreventable diseases
■ Incept Polio lab in the national (VPD) ad communicable
health system diseases surveillance system
■ Certify eradication of WPV
■ Contain all polioviruses
Measles SIAs ■ Conduct two Measles follow ■ Conduct follow up measles SIA ■ Eliminate measles One
up SIAs and achieve ≥95% ■ Improve quality of measles SIAs
coverage by 2025. and monitor performance
Maternal and ■ Sustain MNT road map ■ Considering school Td ■ Maintain MNT elimination One
Neonatal Tetanus ■ ■ (<1/1,0000LB it is also proxy
SIAs indicator of MT)
Meningitis A ■ Prevent Meningococcal ■ Conduct catch up Men A mass ■ Eliminate Meningococcal One
vaccination Meningitis epidemic till 2025 vaccination campaign by 2022 Meningitis by 2030 (global
campaign and beyond ■ Men A introduced into routine Target)
immunization
Polio ■ Achieve AFP surveillance ■ AFP surveillance maintained in ■ Sustain polio free (both W Two
performance indicator targets in all Woredas with government and vDPV)
all Woredas and environmental ownership, AFP surveillance ■ Support the polio eradication
surveillance in select areas. indicators achieved. program
■ Expand the environmental sites ■ Expand the environmental sites
to be collected twice per month to be collected twice per month
for a period of 6 months after for a period of 6 months after
69
70
NATIONAL PRIORITIES NIP OBJECTIVES NIP MILESTONES Global/AFRO Order of
Immunization Supply chain goals priority
Inadequate capacity and weak Improve optimal CC capacity through By 2025 all planned CCE installed
cold chain maintenance, Sub deployment& installation of CCE.
optimal CCE By 2023 CCE maintenance system established.
Establish cold chain maintenance system.
Poor temperature monitoring By 2023 Temperature monitoring system
system Establish temperature monitoring at established and implemented in all vaccine
storage and transportation storage & transportation sites
Poor cold chain inventory and Establish Data base for CCEI By 2025, national automated CCEI management
maintenance management system established
system
Low EVMA score nationally Capacity building of focal persons 2023 EVM score achieved >80% EVM score >80%
71
72
NATIONAL PRIORITIES NIP OBJECTIVES NIP MILESTONES Global/AFRO ORDER
REGIONAL GOALS
Lack of immunization demand To develop a budgeted By 2022, National Immunization Demand 3
generation plan of action at National Immunization Generation Plan of Action developed and
the national and sub-national Demand Generation Plan of implementation initiated
level Action by 2022
Limited strategies which are To develop, implement, By 2025, at least five tailored immunization demand 3
tailored for the communities monitor and evaluate strategies have been developed, implemented,
with high number of zero- tailored immunization monitored and evaluated for the socially/
dosed and under-immunized demand strategies by 2024 geographically hard to reach communities by using
children people-centered approach
Lack of specific interventions To mainstream gender- By 2025, communication materials, messages and 3
addressing gender related sensitiveness in every activities developed for the immunization practices
barriers to seek immunization immunization messages and are gender-sensitive
services activities by 2025
Lack of awareness on the To increase awareness By 2023, standardized, produced and disseminated 3
importance of immunization of the community on the communication materials on immunization in at
and the schedule among the importance of immunization least five local languages
community members which to 95% by 2025
result from the shortage
of job aids and other IEC
materials on immunization for
awareness raising
Weak involvement of media To strengthen relationship, By 2022, national, regional and community 3
in immunization messages engagement, capacity and media agencies sustain their engagement in the
dissemination involvement of different immunization demand generation activities with
media agencies in a high media coverage around immunization
immunization activities/events such as African Vaccination Week,
World Polio Day, etc. and support dissemination of
program by 2022 immunization messages to the community via their
media channels
73
74
NATIONAL PRIORITIES OBJECTIVES MILESTONES Global/ AFRO ORDER OF
Program management REGIONAL PRIORITY
GOALS
Immunization data quality Improve EPI data quality and attain 90% HFs attain Penta 3 data discrepancy of +10% between all countries
and use at all level the acceptable level (within +10%) of registration book and data on DHIS2 by 2025 collect quality
data discrepancies on immunization immunization 1
in all health facilities and local use data though
of immunization data for quality building local
improvement. capacity to use
Improve routine admin data quality with Routine data quality verified at all level with internal innovation
internal and external verification methods mechanisms (eg. though quality improvement team,
performance monitoring team, etc monthly at PHCU and
quarterly at woredas) and use of local coverage validation
tools
75
76
NATIONAL PRIORITIES OBJECTIVES MILESTONES Global/ AFRO ORDER OF
(Strengthening human and REGIONAL GOALS PRIORITY
institutional resources)
Absence posts in the structure Improve staffing pattern to Review the exiting EPI structure by 2021
for EPI coordinators at national, include EPI managers and
regional and zonal levels coordinators post at national and Advocacy for senior management of the
regional levels ministry by 2022
Establish data base system to Establish and fully implement HIRIS data
trach trainees base by the end of 2023.
77
78
NATIONAL PRIORITIES OBJECTIVES MILESTONES Global/ AFRO ORDER OF
(Strengthening human and REGIONAL GOALS PRIORITY
institutional resources)
Inadequate capacity of Enhance the capacity of Plan full advanced research methodology
institutions to conduct institutions to conduct research studies to increase the capacity in 2021-
operational research on EPI through training and financial 2022
support
Build partnership with donors to mobilize
technical and financial supports from 2022-
2023
Establish EPI training center of Initiate discussion with WHO Afro IST/inter
excellency country support by 2022
79
3.8 Planning by immunization system component
80
Service Delivery and New Vaccine Introduction
NATIONAL OBJECTIVE STRATEGY KEY ACTIVITIES 2021 2022 2023 2024 2025
■ To achieve 98% Penta 1 coverage nationally and ■ RED/REC approach Conduct bottleneck assessment and context X X X X X
at least 95% in every district by 2025. implementation in every specific micro planning workshops in all
district and kebeles districts and PHCUs with the involvement of
■ To achieve 95% Penta 3 coverage nationally and
95% and above in every district by 2025. community.
Conduct house to house registration of X X X X X
■ To achieve 93% MCV 1 coverage nationally and
target groups
90% and above in every district by 2025.
Conduct RED/C strategy evaluation X
■ To achieve 87% MCV 2 coverage nationally and
85% and above in every district by 2025. ■ Plan to reach all kebeles at Implement routine immunization X X X X X
■ To achieve 85% fully immunization coverage least four times per year in improvement roadmap in zones with large
nationally and 80% in every district by 2025. difficult to reach areas and number of unimmunized children and regions
areas with large number of require special support
■ Reduce DTP-HepB-Hib1(Penta 1)- DTP-HepB-Hib3 unvaccinated children using
(Penta 3) dropout rate to 3% nationally and less HWs and HEWS
than 5% in all districts by 2025.
■ Capacity building for EPI Training of HWs and EPI managers on RED/C X X X X X
■ Reduce DTP-HepB-Hib1(Penta 1)- MCV1 dropout managers and health strategy, MLM, IIP, and IRT
rate to 5% nationally and less than 7% in all workers
districts by 2025. ■ Design and implement Organize and deploy mobile health teams X X X X X
■ Reduce MCV1-MCV2 dropout rate dropout rate to context specific and for pastoralist and other hard to reach
6% nationally and less than 10% in all districts by appropriate strategy for populations
2025. pastoralist and urban areas PIRI implementation in hard to reach districts X X X X X
■ Reduce proportion of woredas with less than 80% (training, service delivery, supportive
Penta 3 coverage to zero supervision, and review meeting)
Conduct assessment on implementation X
■ Ensure availability of immunization service in all
status and outcome of PIRI
HF (Hospitals, Health centers and Health posts) by
2025. Implementation of tailored strategy to X X X X X
address unreached segments of urban
community
■ Intensify defaulter tracing Defaulter tracing using HDAs/Community X X X X X
through strengthening volunteers
available community
platforms and structures
■ Integration of EPI with other Circular for all regions to monitor integration X X X X X
services to reduce missed of immunization service with other Maternal,
opportunity Neonatal and Child health services
Integration of immunization service with X X X X X
other Maternal, Neonatal and Child health
services
■ Avail vaccination service Delivery of vaccination service on daily basis X X X X X
whenever and wherever by all health facilities
needed Monitor outreach sessions are conducted as X X X X X
per the plan
81
82
NATIONAL OBJECTIVE STRATEGY KEY ACTIVITIES 2021 2022 2023 2024 2025
■ Introduce COVID-19 Vaccine, nOPV2 and piloting ■ leadership strengthening for Apply for MR, IPV2, Mena A, Hep BBD and X X
of Hepatitis B birth dose by 2021, introduce MR new vaccine introduction Yellow Fever vaccine introduction plan
and IPV2, scale introduction of Hepatitis B birth Strengthen new vaccine introduction X X X X X
■ Capacity building on new
dose, Yellow fever, Men A vaccine by 2022. vaccine introduction at all taskforce
levels Training of health workers and EPI program X X X X X
■ Advocacy and consensus managers
building Introduce IPV2 X
■ Expansion of Cold chain Introduce MR X
Storage space
■ Evaluate vaccine Introduce Men A X
management practices Introduce YF X
■ Revision of monitoring tools COVID-19 and other emergency
Men A Catch-up Men A vaccine Catch-up Men A SIA by 2022 in susceptible population X X X
Prevent meningococcal
meningitis outbreaks
all through , 2021 to
025
83
84
NATIONAL STRATEGY KEY ACTIVITIES 2021 2022 2023 2024 2025
OBJECTIVE
II. Surveillance and Accelerated Disease Control
AFP ■ Strengthen and monitor case and ■ Follow-up assessment and regular Supervision X X X X X
lab-based AFP surveillance and
Achieve AFP achieve performance indicator
surveillance targets in all Woredas
performance indicators
■ Expand environmental surveillance
targets in all Woredas
sites ■ Monitoring and data harmonization with AFP X X X X X
and environmental
surveillance in selected ■ Integrate VDP surveillance in the surveillance indictor
areas. context of COVID 19 pandemic
response
■ Emphasis to enhancing
government ownership of AFP ■ Regions and partners orientation and training X X X X
surveillance activities health workers regarding AFP surveillance in the
context of COVID-19.
Achieve measles
based measles surveillance Supervision
surveillance integrated with rubella
performance indicator to achieve performance
targets in all Woredas indicators in all Woredas,
with emphasis to enhancing
government ownership.
■ Mobilize additional funds
■ Monitoring and data harmonization with X X X X X
to bridge funding gaps to
85
86
NATIONAL STRATEGY KEY ACTIVITIES 2021 2022 2023 2024 2025
OBJECTIVE
Pediatrics bacterial Upgrade/strengthen the coordination between ■ Arrange regular forum between X X X X X
meningitis: Men A case based & lab-based surveillance two parties
system with Central /Regional laboratories
Establish case- ■ Conduct joint supportive
based Meningitis A
surveillance by 2022
supervision
■ Create Orientation/training
opportunities
Laboratory
Polio Lab: Expand ■ Sewage samples collected ■ Coordination meeting with the site X X X X X
environmental twice per month for a period coordinators
sampling sites of AFP
of 6 months after the last ■ Capacity building of surveillance officers
OPV campaign. and subnational lab team member about
■ Initiation of molecular test CRS
for measles and Strengthen
the CRS sentential sites
87
88
Objectives Strategies Activities 2021 2022 2023 2024 2025
■ Conduct capacity building X X X
activities.
■ Maintain temp monitoring ■ Establish state of the art cold chain maintenance workshops/
devices and formats facilities and training centers at new and existing institutions,
availability and quality. (such as in Debremarkos, Jimma, Gondor and Addis Ababa
university, Tegbareid TVET, etc) and others.
■ Make temperature
monitoring components a
performance indicator
■ Conducting periodic temperature monitoring studies and conduct X X
calibration:
Ensure storage and
■ Map the cold rooms and refrigerated vehicles temp /new and
transportation equipment
maintain a standard existing
Improve the Cold chain temperature ■ Conduct calibration periodically /for new and after repair
management works for cold rooms and refrigerated vehicles.
■ Establish mechanisms to monitor temperature during transport by
procuring and installing of RTMDs
Establish mechanisms to ■ Establish formal temperature reviewing team X X X X X
maintain temperature record
■ Establish reporting and feedback system in hard/soft copy on
traces and reviewed
temperature monitoring and schedule periodic temperature review
exercise (at least once per month) at all level
89
Advocacy, social mobilization and program communication
90
NATIONAL OBJECTIVE STRATEGY KEY ACTIVITIES 2021 2022 2023 2024 2025
Increase demand, knowledge, ■ Multi-faceted demand Update, print and distribute immunization X X X X
attitude and practices of the generation strategies including communication materials and tool for HEW by
community on immunization services advocacy, social mobilization, 2022.
utilization at least 5% from the community engagement,
baseline by 2025. tailored interventions and risk Develop National Demand Generation on X X
communication to eliminate Immunization Plan of Action and Comprehensive
rumours and misconceptions immunization risk communication guideline
around vaccination and to
Ensure HEW have planned community dialogue on X X X X X
build trust in the immunization
immunization annually
services
Establish social media pages for immunization X x x x x
communication by 2021
Four TV and Radio spots on routine immunization X X X X X
annually.
TV and radio dialogs on immunization annually X X X X X
Hotline services on immunization communication X X X X X
Short SMS messages 2X annually X X X X X
Sensitize and Utilize town criers and social X X X X x
mobilizers for immunization communication
Develop messages on AEFI communication X X
Harmonize, develop and distribute messages(TV X X X X X
spot, radio spot, IEC/BCC materials etc) for
new vaccine introductions, SIAs and routine
immunizations
Develop SMS messages and communicate X X X X X
on vaccine-preventable diseases surveillance
annually.
91
92
NATIONAL OBJECTIVE STRATEGY KEY ACTIVITIES 2021 2022 2023 2024 2025
Improve IPC skills of health workers ■ Improve health workers’ Develop IPC training manual for health workers X X
in 75% of health facilities by 2025. interpersonal communication
Conduct IPC skills trainings for health workers X X X X
capacity
Conduct two Researches to assess ■ Monitor and evaluate Conduct baseline assessment on immunization X X
immunization communication utilization of immunization communication outcomes by using Behavior and
intervention outcomes communication interventions Social Drivers (BeSD) tools for immunization
Conduct IEC/BCC material distribution auditing X X
93
94
NATIONAL OBJECTIVE STRATEGY KEY ACTIVITIES 2021 2022 2023 2024 2025
Strengthen coordination Ensure engagement at highest level
Continue collaborating with E-NITAG X X X X X
platforms for immunization at of immunization program
all level Establish/revitalize immunization/child survival TWG/TF at
X X X X X
reginal, zonal and woreda level
Designate responsible person for
coordination
95
Strengthening human and institutional resources
96
Human Resource for immunization 2021 2022 2023 2024 2025
Objectives Strategies
Core Activities
Improve health ■ conducting need Conduct training based on need assessment tool findings by end of 2021 50 60 65 70 51%to
workers capacity based trainings, 80%
■ Conduct two training impact assessment by the end of 2025
■ Increase training access for frontline health workers, health managers
and focal persons by the end of 2025
■ Improve skills and practice of Health workers on EPI; Increase vaccine
management knowledge among health workers from current score of
51%to 80% as measured by EVMA by 2025
■ Achieve MLM training in 80% of districts by 2025
■ To achieve IIP training for >90% of front line HWs who are providing
immunization services
■ Achieve RED/REC training for > 90% HWs working in EPI
■ Achieve data management training (EDQS) for 80% HWs working in
EPI
■ Achieve training on VPD surveillance for 80% HWs working in
vaccine-preventable disease surveillance.
■ Strengthen EPI program training in pre-service education to 50% of
health teaching colleges.
■ Increase training access for frontline health workers, health managers
and focal persons by the end of 2025
■ Initiate vaccinology course training
■ incentives and ■ Link in service training(CPD) with promotion and licensure from 2021- X x
Improve health motivations and 2025
work staffs include pre service
turnover
■ curricula for
Improve Health Implement integrated Establish and fully implement HIRIS data base by the end of 2023. X
sector human health information
X X X x x
resource system(iHRIS)
Enhance the Plan full advanced research methodology studies to increase the capacity X
capacity of in 2021-2022
Strengthen partnership
institutions Build partnership with donors to mobilize technical and financial supports X X X x x
and cooperation
to conduct from 2022-2023
research
Establish EPI Cooperation Strengthen Initiate discussion with WHO Afro IST/inter country support by 2022 X X x x x
training center Advocate with government to establish the excellency centers by 2022 X X x x x
of excellency
97
98
Human Resource for immunization 2021 2022 2023 2024 2025
Objectives Strategies
Core Activities
Initiate Conduct feasibility studies to assess local production of the country by
discussion for Strengthen partnership 2021-2022
local vaccine and cooperation Sharing the findings with appropriate Authorities
production Conducting mentorship to training centers of excellency
capacity in Strengthen mentorship
Ethiopia.
X
Develop improvement plan
Strengthen Regular Advocate with partners to conduct EVMA at regional and zonal levels to x
performance monitoring develop continues improvement plan following EVMA
Engage and sustain EPI ■ Facilitate joint planning meeting and share X X X X X
partners throughout the plan with government, partners and
Develop and strengthen joint stakeholders
the program planning,
annual planning, implementation, ■ Conduct joint supervision at all levels (National, X X X X X
implementation and
monitoring and evaluation Regional, and zonal)
monitoring
■ Advocating and sharing the CMYP for potential X X X X X
X X X X X
Secure the required funds for Engage the community members, ■ Create flexible and open platform to different X X X X X
EPI program partners, officials, and other partners to take part in the CMYP activities/
objectives.
stakeholders in facilitation,
administration and coordination of ■ Mobilize community X X X X X
the vaccines delivery.
■ Map available resource mapping within the X X X X X
community, partners and stakeholders
■ Increase local authorities’ participation X X X X X
99
04 Costing, Financing and
CHAPTER Financing Gaps
Total Health Expenditures per capita 9.46 11.04 12.87 15.02 17.52 20.44
(THE per capita) in USD
Government Health Expenditures (GHE %) 11.6 12.1 12.7 13.2 13.8 14.5
Data extrapolated from cMYP 2016 to 2020 with similar assumption
4.2 Methodology for costing the cMYP GDP growth based on WHO/NHA database; and
Disease Programme activity standards.
The cMYP 2021-2025 costed using OneHealth
Tool (OHT). This tool is built on six health system 4.2.1: Costing Assumptions
building blocks, drawing upon the WHO framework
on health systems that include health workforce, Targets were set using the available evidences from
infrastructure, logistics and supply chain, health the EPI surveys such as EDHS, WUNIC estimates,
information system, health systems financing, routine DHIS_2 administrative data and expert
leadership and governance. OHT is a policy opinions. Inputs for the tool were completed
projection-modeling tool that allows users to create through series of consultative workshops with EPI
short- and medium-term plans for scaling up health partners, program experts and stakeholders. List of
services. It is used for health planning, costing and priority Immunization interventions were identifies
budgeting with a focus on integrating planning and and prioritized prior to entry to OneHealth Tool for
financial space analysis. The tool is also organized costing and Target setting. Then the tool generated
into three components: health systems, health overall program cost and Targets considering existing
services delivery, and impact module. The tool interventions and no additional investments such as
comprises different country specific default data infrastructure expansion. The costing and Target
like; Baseline situation analysis (Epidemiology, assumptions are designed to be linked to cv000
Demography, current coverage, etc…); Intervention live births, Infant Mortality from 47 to 36/1000 live
standards (drug and supply cost per average case births and Under Five Mortality from 59 to 44/1000
based on WHO treatment guidelines + international live births in line with the HSTP II.
Vaccine prices from UNICEF, MSH and IDA, estimated
The cost implications for the proposed program
personnel type & time required); Expenditures &
activities and how they are related to the available
102
FUTURE BUDGET REQUIREMENTS
EXPENDITURES
COST CATEGORY
IN 2020 2021 2022 2023 2024 2025 TOTAL 2021-2025
Vaccines (routine only) 71,132,478.60 49,073,644.4 53,612,482.75 58,482,660.03 63,349,704.08 68,300,685.21 292,819,176.5
NVI with Injection Supplies 65,492,828.65 210,087,610.35 89,446,087.7 75,346,354.94 56,042,311.3 496,415,192.99
Campaigns with Injection
482,862.1 40548544.59 56,790,621.57 36,412,207.03 31,994,682.54 166,228,917.83
Supplies
EPI Operational Research - - - 120,000.00 - 120,000.00
According to the National Health Accounts to increase Immunization financing both for routine
2016/17, the Government contribution to the immunization and New Vaccine Introductions in the
Total Heath Expenditure has increased from 30% next five years strategic cMYP (2021-2025). The
to 32%. Ethiopia has been covering the cost of increase in the share of the government contribution
traditional Vaccines and sharing the cost of NVIs to Health is encouraging, as this pushes the Health
in the past cMYP period. The MOH is committed Sector towards more financial sustainability
105
Frequency Baseline Targets
106
Immunization System
Suggested Indicators of Source of data
Subcomponent EDHS
reporting 2021 2022 2023 2024 2025
2019/2020
Number of Measles SIAs conducted
every two SIAs admin and
from targeted catch-up measles NA 0 1 0 1 0
year survey report
Measles vaccination camping in the 5 year.
Percentage of children vaccinated every two SIAs admin and
NA 0 95% 0 95% 0
during the Measles SIAs year survey report
Number of bOPV SIAs conducted
SIAs admin and
from targeted preventive vaccination Bi-Annually NA 2 2 2 2 2
survey report
Polio campaign in the 5 year.
Percentage of children vaccinated SIAs admin and
Bi-Annually NA 95% 95% 95% 95% 95%
during the bOPV preventive SIAs survey report
SIAs
Number of Men A catchup SIAs
SIAs admin and
conducted from targeted vaccination Annually NA 0 1 0 0 0
survey report
Men A campaign in the 5 year.
Percentage of children vaccinated SIAs admin and
Annually NA 0 95% 0 0 0
during the Men A catch-up SIAs survey report
Number of yellow fever catch-up SIAs
SIAs admin and
conducted from targeted vaccination Annually NA 0 1 0 0 0
survey report
Yellow fever campaign in the 5 year.
Percentage of children vaccinated SIAs admin and
Annually NA 0 95% 0 0 0
during the yellow fever catch-up SIAs survey report
107
Reference
2. World Health Organization 2016: Global Routine Immunization Strategies and Practices (GRISP), A
companion document to the Global Vaccine Action Plan (GVAP).
3. Immunization Agenda 203: A Global Strategy To Leave No One Behind National, draft four, April 2020. 4.
WHO: National Immunization Strategy - Guidance Document (final draft), May 2020.
4. WHO: WHO-UNICEF Guidelines for Comprehensive Multi-Year Planning for Immunization, Update
September 2013.
5. WHO: Guide for the Development of National Immunization Policies in the African Region (draft), July
2016.
6. WHO Regional Office for Africa, 2015: Regional Strategic Plan for Immunization 2014-2020.
7. Roadmap for Implementing the Addis Declaration on Immunization: Advocacy, Action, and Accountability,
March 2017.
8. GAVI: 2021-2025 high level strategy to leave no-one behind with immunization.
10. World Health Organization 2018: A practical handbook for planning, implementing, and strengthening
vaccination in the second year of life.
11. World Health Organization 2018: Establishing and strengthening immunization in the second year of life
Practices for vaccination beyond infancy.
12. World Health Organization 2017: Planning Guide to Reduce Missed Opportunities for Vaccination. 14.
Urban Immunization Toolkit. New York: United Nations Children’s Fund; 2018: Urban Immunization A tool
kit for those planning to address inequitable immunization coverage in the urban context, September
2018.
13. World Health Organization 2018: Working together an integration resource guide for immunization
services throughout the life course.
14. Services Availability and Readiness Assessment (SARA); Ethiopian Public Health Institute, ETHIOPIA,
2018.
15. Achieving and Sustaining Maternal and Neonatal Tetanus Elimination: Strategic Plan 2012–2015; UNICEF,
WHO, UNFPA.
16. Comprehensive Multi-Year Plan 2016 – 2020, Federal Ministry of Health, Addis Ababa, April, 2015. 19. Epi
Policy Implementation Guideline, 2018 (Draft), Ministry of Health of Ethiopia.